136 results
Page 4 of 7
8-K
EX-1.1
bob21otuxgn9 iusc22n
22 Jan 20
Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
5:30pm
424B5
3r8 r11o6wesf82c010
21 Jan 20
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
cd2 tbh92lr8utujws0e
6 Nov 19
Adaptimmune Reports Third Quarter 2019 Financial Results and Business Update
7:35am
8-K
EX-10.1
erc2movyyonuvrz3z y7
27 Aug 19
Entry into a Material Definitive Agreement
8:39am
8-K
EX-10.4
shzmir j4mqum2vrpcyb
27 Jun 19
Departure of Directors or Certain Officers
8:08am
8-K
EX-99.1
9atv io5e0i
15 May 19
Adaptimmune and Alpine Immune Sciences Announce Collaboration and License Agreement to Develop Next-Generation SPEAR T-Cell Products
8:11am
CORRESP
lcgp3 ao7346z90vy
3 Dec 18
Correspondence with SEC
12:00am
CORRESP
ao70qyy4
18 Oct 18
Correspondence with SEC
12:00am